Maximising revenue growth
Even in an environment of heightened regulatory scrutiny, slow product approval, mounting payer demands for product performance and increasing pricing pressure, there are still viable strategies for maximising revenue. More on maximising revenue growth
Managing the effective tax rate
The regulatory burden imposed on the pharma sector and increasing scrutiny of international tax structures by the authorities are putting pressure on effective tax rates in the sector. Understanding the impact of these developments on profitability is vital. More on managing the effective tax rate
High-quality corporate reporting
Identifying differences in generally accepted accounting practice, industry specific insight for IFRS conversions, valuing intangible assets, structuring alliances, licensing management and royalty audits – reporting requirements today call for sophisticated solutions. More on high-quality corporate reporting
R&D productivity and the innovation deficit
The era of blockbuster drugs is over, productivity in the lab is plummeting as R&D shifts its focus to less common, more complex diseases, and the ballooning 'innovation deficit' has enormous strategic implications for the industry as a whole. Urgent action is needed to increase the cost efficiency and output of core R&D. More on R&D productivity and the innovation deficit
Efficient regulatory & compliance management
Regulatory change results in constantly shifting dynamics in the life sciences sector, and the trend towards worldwide harmonisation has far-reaching implications for the introduction of new technologies, manufacturing strategies and business models. A strong international compliance programme is essential. More on efficient regulatory & compliance management
Realising value from M&A, alliances and collaborations
The life sciences sector looks increasingly to mergers & acquisitions, licensing, alliances and joint ventures to deliver shareholder value. Due diligence and proper pre- and post-deal planning of integration issues at all levels – financial, legal, operational, systems and regulatory – is crucial. More on realising value from M&A, alliances and collaborations
Ensuring pharmaceutical supply chain effectiveness
Pharma companies are outsourcing non-core manufacturing to emerging markets, and re-gearing their supply models to match shifts in the provision of care (e.g. direct to consumer or pharmacist rather than through a wholesale channel). More sophisticated tools will be needed for supply chain management, from operations to finance and tax planning. More on ensuring pharmaceutical supply chain effectiveness
Attracting and retaining skilled workforce
Demand for skilled people is growing while traditional labour markets are providing fewer people with the right qualifications and experience. Strategy, planning, tax efficient rewards, employment law, international mobility, incentives: HR is faced with challenges at all levels. More on attracting and retaining a skilled workforce
Romain Seffer
Sofie Van Grieken
